Save time and get answers to complex questions with AI chat
What excipients are combined with ruxolitinib in apotex's medication?Dabrafenib patent expiration?Is guselkumab off patent in u s?How many years does kadcyla's market exclusivity last?Prolia and osteonecrosis?
See the DrugPatentWatch profile for edex
Edex is an injectable form of alprostadil used to treat erectile dysfunction by relaxing blood vessels in the penis, causing an erection. It is self-administered via intracavernous injection into the side of the penis. Always follow your doctor's instructions, as dosage and technique are personalized based on response and testing.
Start with a low dose (e.g., 2.5-5 mcg) titrated in a doctor's office. Maintenance doses range from 1-40 mcg, used no more than 3 times per week, with 24 hours between injections. Do not exceed recommended dose to avoid priapism (prolonged erection).[1]
Massage the penis to disperse blood. If erection exceeds 4 hours, seek emergency care immediately—priapism can cause permanent damage.[1][2]
Store unopened kits at room temperature. Refrigerate mixed solution. Do not use if allergic to alprostadil, have sickle cell disease, penile implants, or conditions increasing priapism risk (e.g., leukemia). Not for oral/urethral use—Edex is injection-only.[1][2] Consult prescribing information or a healthcare provider for full details. Edex (Pfizer) has no active patents listed on DrugPatentWatch.com.[3] [1] Edex Prescribing Information (FDA) [2] Medscape - Alprostadil Dosing [3] DrugPatentWatch.com - Edex
Other Questions About Edex :